Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia

Jiang Cao, MD, Hai Cheng, MD, Kunming Qi, Wei Chen, Ming Shi, Junnian Zheng, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 3872.

https://doi.org/10.1182/blood-2019-128286

Published: 2019

Journal Articles

Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Anne Angiolillo, MD, Reuven J. Schore, MD, John Kairalla, Meenakshi Devidas, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MD PhD, Michael J. Borowitz, MD PhD, Brent L Wood, MD PhD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Mary V. Relling, PharmD, Ashley Lane, Kelly Maloney, MD, Cindy Wang, MS, William L. Carroll, MD, Naomi Winick, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2019) 134 (Supplement_1): 824.

https://doi.org/10.1182/blood-2019-123565

Published: 2019

Journal Articles

Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Anne Angiolillo, MD, Reuven Schore, MD, Meenakshi Devidas, Xiaomin Lu, PhD, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MDPhD, Michael Borowitz, MD PhD, Brent Wood, MDPhD, Andrew J. Carroll, III, PhD, Nyla A. Heerema, PhD, Cindy Wang, MS, Kelly Maloney, MD, Naomi Winick, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2017) 130 (Supplement 1): 140.

https://doi.org/10.1182/blood.V130.Suppl_1.140.140

Published: 2017

Journal Articles

Effect of High-Dose Methotrexate (HD-MTX) Vs Capizzi Methotrexate/Pegaspargase (C-MTX/ASNase) on Osteonecrosis (ON) Incidence in Children and Young Adults with T-Acute Lymphoblastic Leukemia (T-ALL): Results of Children’s Oncology Group (COG) Study AALL0434

Leonard A. Mattano, MD, Meenakshi Devidas, PhD, Si Chen, MS, Natia Esiashvili, MD, Barbara Asselin, MD, Naomi J. Winick, MD, Mignon Loh, MD, Elizabeth A Raetz, MD, Stephen Hunger, MD, William L. Carroll, MD, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD

Blood (2014) 124 (21): 3649.

https://doi.org/10.1182/blood.V124.21.3649.3649

Published: 2014

Journal Articles

Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331

Leonard A. Mattano, MD, Meenakshi Devidas, PhD, Alison M. Friedmann, MD MSC, Elizabeth A. Raetz, MD, Mignon Loh, MD, Patrick Buckley, MD PhD, Michael J. Borowitz, MD PhD, Andrew J. Carroll, PhD, Julie Gastier-Foster, PhD, Nyla A. Heerema, PhD, Nina Kadan-Lottick, MD MSPH, Yousif Matloub, MD, David T Marshall, MD, Linda C. Stork, MD, Brent L. Wood, MD PhD, Naomi J. Winick, MD, Stephen Hunger, MD, William L. Carroll, MD, Kelly Maloney, MD

Blood (2014) 124 (21): 793.

https://doi.org/10.1182/blood.V124.21.793.793

Published: 2014

Journal Articles

Novel Therapy with Interferon-α in Combination with Donor Lymphocyte Infusion for High Risk Acute Leukemia Patients Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

XiaoWen Tang, MD, Qianlan Zhou, Zhengming Jin, Chengcheng Fu, Chunmei Ye, Xiaolan Shi, Xiaohui Hu, Biyun Peng, Fan Ye, Yuxia Lu, Ziling Zhu, Yufeng Feng, Huirong Chang, Aining Sun, Wu Depei, MD, PhD

Blood (2011) 118 (21): 658.

https://doi.org/10.1182/blood.V118.21.658.658

Published: 2011

Journal Articles

Longer Time to the Start of Continuation Therapy Is Associated with Improved Survival In High Risk Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG)

Marla H Daves, MD, Stephen Hunger, MD, Stephen B Linda, MS, W. Paul Bowman, MD, Nita L. Seibel, MD, Lillian Sung, MD, PhD, Meenakshi Devidas, PhD

Blood (2010) 116 (21): 3223.

https://doi.org/10.1182/blood.V116.21.3223.3223

Published: 2010

Journal Articles

The Long-Lerm Follow-Up of Childhood Acute Lymphoblastic Leukemia Treated in China with Chemotherapy under Poor Coverage of Medical Insurance: A Single Center Experience.

Yongmin Tang, MD, Hua Song, MD, Shuwen Shi, MD, Shilong Yang, MD, Jian Wei, MD, Weiqun Xu, MD, Binhua Pan, MD, Yinghu Chen, MD, Lingyan Zhang, MD, Fenying Zhao, MD, Botao Ning, PhD, Xiaojun Xu, MS

Blood (2005) 106 (11): 4580.

https://doi.org/10.1182/blood.V106.11.4580.4580

Published: 2005

Journal Articles

Intermediate Dose Methotrexate in Low-Risk Acute Lymphoblastic Leukemia. Results of the FRALLE 93A Protocol.

Yves Perel, Hervé Chambost, Virginie Gandemer, Thierry Leblanc, Schneider Pascale, Schmitt Claudine, Mariane Debré, Christiane Vermylen, Gérard Couillault, Jean-Paul Lamagnere, Marie-Françoise Auclerd, Guy Leverger, André Baruchel, the FRALLE group

Blood (2004) 104 (11): 1949.

https://doi.org/10.1182/blood.V104.11.1949.1949

Published: 2004

NARROW

Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia

Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Effect of High-Dose Methotrexate (HD-MTX) Vs Capizzi Methotrexate/Pegaspargase (C-MTX/ASNase) on Osteonecrosis (ON) Incidence in Children and Young Adults with T-Acute Lymphoblastic Leukemia (T-ALL): Results of Children’s Oncology Group (COG) Study AALL0434

Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331

Novel Therapy with Interferon-α in Combination with Donor Lymphocyte Infusion for High Risk Acute Leukemia Patients Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Longer Time to the Start of Continuation Therapy Is Associated with Improved Survival In High Risk Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG)

The Long-Lerm Follow-Up of Childhood Acute Lymphoblastic Leukemia Treated in China with Chemotherapy under Poor Coverage of Medical Insurance: A Single Center Experience.

Intermediate Dose Methotrexate in Low-Risk Acute Lymphoblastic Leukemia. Results of the FRALLE 93A Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only